# US 11,028,452 B2 · Assay for the diagnosis of dermatophytosis > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 11,028,452 B2 - Document ID: US11028452B2 - Status: Granted - Kind: B2 - Application number: 15/938,890 - Filed: 2018-03-28 - Published: 2018-10-11 - Granted: 2021-06-08 - Earliest claimed: 2017-03-30 - Assignees: EUROIMMUN Medizinische Labordiagnostika AG - Applicants: Euroimmun Medizinische Labordiagnostika AG - Inventors: Melanie Harder; Yvonne Graeser; Christiane Kupsch; Markus Cavalar - Web page: https://patentgrep.com/patent/US11028452B2 ## CPC - C12Q 1/6895: for plants, fungi or algae - C12Q 1/6851: Quantitative amplification - C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES ## Abstract The present invention relates to a primer pair comprising a forward primer and a reverse primer for amplifying a nucleic acid from a pathogen associated with a skin, hair and nail infection comprising SEQ ID NO:22, a nucleic acid capable of hybridizing specifically to a nucleic acid sequence from a pathogen associated with a skin, hair and nail infection comprising SEQ ID NO:22, a carrier comprising the nucleic acid, a method comprising the step detecting in a sample a nucleic acid sequence comprising SEQ ID NO:22 from a pathogen associated with a skin, hair and nail infection, a use of the primer pair, the nucleic acid or the carrier for the diagnosis of a disease and a kit comprising the primer pair, the nucleic acid and/or the carrier for the diagnosis of a disease. ## Claims ### Claim 1 A primer pair, comprising: a forward primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the forward primer, and having a final base of the forward primer no more than 200 bp away from a first base of SEQ ID NO: 1 in a 5′ to 3′ orientation, and a reverse primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the reverse primer, and having a final base of the reverse primer is no more than 200 bp away from a final base of SEQ ID NO: 1 in the 5′ to 3′ orientation, wherein each of the forward primer and the reverse primer are labeled with a label and form the primer pair, wherein the label is selected from the group consisting of a fluorescent label, a radioactive label, a colloidal gold label, and an enzymatically active label, wherein the forward primer and reverse primer, in combination, amplify a nucleic acid comprising a sequence having at least 98% identity to the full-length of SEQ ID NO: 1 from a human pathogenic dermatophyte that causes at least one of a skin, hair, and nail infection, the human pathogenic dermatophyte belonging to a Trichophyton genus. ### Claim 2 A nucleic acid probe, comprising: a modified nucleic acid comprising a 5′ C6-amino-linker, wherein the modified nucleic acid is capable of hybridizing specifically to a nucleic acid sequence from a single species of a human pathogenic dermatophyte that causes at least one of a skin, hair, and nail infection, the human pathogenic dermatophyte belonging to a Trichophyton genus, wherein the nucleic acid sequence from the human pathogenic dermatophyte comprises at least one of the sequence that is at least 98% identical to the full-length of SEQ ID NO: 1, a strand complementary to SEQ ID NO: 1, or SEQ ID NO: 1 in a vector or cell, wherein the modified nucleic acid is at least 95% identical to at least one of the full-length of SEQ ID NO: 1, the strand complementary to SEQ ID NO: 1, or SEQ ID NO: 1 in the vector or cell, over a length of at least 15 consecutive nucleotides, and wherein the length of the nucleic acid probe is no more than 200 nucleotides. ### Claim 3 (depends on 1) The nucleic acid amplified from the human pathogenic dermatophyte by the primer pair according to claim 1, wherein the nucleic acid comprises the label, wherein the nucleic acid has at least 98% identity to the full-length of SEQ ID NO: 1, and wherein the nucleic acid is amplified from the human pathogenic dermatophyte belonging to a Trichophyton genus. ### Claim 4 (depends on 2) A carrier comprising the nucleic acid probe according to claim 2. ### Claim 5 (depends on 4) The carrier according to claim 4, wherein the carrier is a silane coated microarray plate made from a material selected from the group consisting of a glass material, a plastic material, or a silicon material. ### Claim 6 A method, comprising: a) obtaining a sample of at least one of nail material, hair material, or skin material, from a patient, b) amplifying, from the sample of the patient, a nucleic acid from a human pathogenic dermatophyte comprising at least one of the sequence that is at least 98% identical to the full-length of SEQ ID NO: 1, a strand complementary to SEQ ID NO: 1, or SEQ ID NO: 1 in a cell, the human pathogenic dermatophyte belonging to a Trichophyton genus, using a primer pair, thereby generating an amplicon, wherein the primer pair comprises: a forward primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the forward primer, and having a final base of the forward primer no more than 200 bp away from a first base of SEQ ID NO: 1 in a 5′ to 3′ orientation, and a reverse primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the reverse primer, and having a final base of the reverse primer no more than 200 bp away from a final base of SEQ ID NO: 1 in the 5′ to 3′ orientation, wherein each of the forward primer and the reverse primer are labeled with a label and form the primer pair, wherein the label is selected from the group consisting of a fluorescent label, a radioactive label, a colloidal gold label, and an enzymatically active label. ### Claim 7 (depends on 6) The method according to claim 6, further comprising: c) detecting the amplicon. ### Claim 8 (depends on 7) The method according to claim 7, wherein the amplicon is detected by fluorescence, radioactivity, colloidal gold, or chemiluminescence. ### Claim 9 (depends on 1) A kit for the diagnosis of at least one of a skin, hair, and nail infection caused by a human pathogenic dermatophyte, comprising: instructions that detail how to use the kit to diagnose at least one of a skin, hair, and nail infection, the primer pair according to claim 1, wherein the primer pair comprises the label, a nucleic acid probe capable of hybridizing specifically to a nucleic acid sequence from the human pathogenic dermatophyte, wherein the nucleic acid probe comprises: a modified nucleic acid comprising a 5′ C6-amino-linker, wherein the nucleic acid sequence from the human pathogenic dermatophyte comprises at least one of the sequence that is at least 98% identical to the full-length of SEQ ID NO: 1, a strand complementary to SEQ ID NO: 1, or SEQ ID NO: 1 in a vector or cell, wherein the modified nucleic acid is at least 95% identical to the full-length of SEQ ID NO: 1, the strand complementary to SEQ ID NO: 1, or SEQ ID NO: 1 in the vector or cell, over a length of at least 15 consecutive nucleotides, and wherein the length of the nucleic acid probe is no more than 200 nucleotides, and a carrier for immobilizing the nucleic acid probe, wherein the carrier is a silane coated microarray plate made of a material selected from the group consisting of a glass material, a plastic material, or a silicon material. ### Claim 10 (depends on 1) The primer pair according to claim 1, wherein the Trichophyton is selected from the group consisting of T. tonsurans, T. equinum, T. interdigitale, T. benhamiae (african), T. benhamiae (yellow), T. concentricum, and T. erinacei. ### Claim 11 (depends on 2) The nucleic acid probe according to claim 2, wherein the Trichophyton is selected from the group consisting of T. tonsurans, T. equinum, T. interdigitale, T. benhamiae (african), T. benhamiae (yellow), T. concentricum, and T. erinacei. ### Claim 12 (depends on 4) The carrier according to claim 4, wherein the Trichophyton is selected from the group consisting of T. tonsurans, T. equinum, T. interdigitale, T. benhamiae (african), T. benhamiae (yellow), T. concentricum, and T. erinacei. ### Claim 13 (depends on 6) The method according to claim 6, wherein the Trichophyton is selected from the group consisting of T. tonsurans, T. equinum, T. interdigitale, T. benhamiae (african), T. benhamiae (yellow), T. concentricum, and T. erinacei. ### Claim 14 (depends on 9) The kit according to claim 9, wherein the Trichophyton is selected from the group consisting of T. tonsurans, T. equinum, T. interdigitale, T. benhamiae (african), T. benhamiae (yellow), T. concentricum, and T. erinacei. ### Claim 15 (depends on 1) The primer pair according to claim 1, wherein the forward primer is capable of binding to a DNA sequence from multiple species of the human dermatophyte, and/or the reverse primer is capable of binding to the DNA sequence from multiple species of the human dermatophyte. ### Claim 16 A primer pair, comprising: a forward primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the forward primer, and having a final base of the forward primer no more than 200 bp away from a first base of SEQ ID NO: 1 in a 5′ to 3′ orientation, and a reverse primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the reverse primer, and having a final base of the reverse primer no more than 200 bp away from a final base of SEQ ID NO: 1 in the 5′ to 3′ orientation, wherein each of the forward primer and the reverse primer are labeled with a label and form the primer pair, wherein the label is selected from the group consisting of a fluorescent label, a radioactive label, a colloidal gold label, and an enzymatically active label, wherein the forward and reverse primer, in combination, amplifies a nucleic acid comprising SEQ ID NO: 1 from a human pathogenic dermatophyte that causes at least one of a skin, hair, and nail infection, the human pathogenic dermatophyte belonging to a Trichophyton genus. ### Claim 17 A kit, for the diagnosis of at least one of a skin, hair, and nail infection caused by a human pathogenic dermatophyte, comprising: a primer pair comprising: a forward primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the forward primer, and having a final base of the forward primer no more than 200 bp away from a first base of SEQ ID NO: 1 in a 5′ to 3′ orientation, a reverse primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the reverse primer, and having a final base of the reverse primer no more than 200 bp away from a final base of SEQ ID NO: 1 in the 5′ to 3′ orientation, wherein each of the forward primer and the reverse primer are labeled with a label and form the primer pair, wherein the label is selected from the group consisting of a fluorescent label, a radioactive label, a colloidal gold label, and an enzymatically active label, wherein the forward primer and reverse primer, in combination, amplify a nucleic acid comprising SEQ ID NO: 1 from the human pathogenic dermatophyte belonging to a Trichophyton genus, and a modified nucleic acid probe comprising a 5′ C6-amino-linker and capable of hybridizing specifically to the nucleic acid amplified by the forward primer and the reverse primer, wherein the modified nucleic acid is at least 98% identical to at least one of SEQ ID NO: 1, the strand complementary to SEQ ID NO: 1, or SEQ ID NO: 1 in the vector or cell, over a length of at least 15 consecutive nucleotides, wherein the length of the nucleic acid probe is no more than 200 nucleotides, wherein the modified nucleic acid probe is specific to a species of the human pathogenic dermatophyte belonging to the Trichophyton genus. ### Claim 18 A modified nucleic acid amplified from a human pathogenic dermatophyte by a primer pair, comprising: a nucleic acid comprising at least 98% identity to the full-length of SEQ ID NO: 1 from the human pathogenic dermatophyte belonging to a Trichophyton genus that causes at least one of a skin, hair, and nail infection; wherein the nucleic acid is labeled with a label to form the modified nucleic acid, wherein the label is selected from the group consisting of a fluorescent label, a radioactive label, a colloidal gold label, and an enzymatically active label; and the primer pair comprising: a forward primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the forward primer, and having a final base of the forward primer no more than 200 bp away from a first base of SEQ ID NO: 1 in a 5′ to 3′ orientation; and a reverse primer having a length of 14 to 30 nucleotides, being at least 90% identical to Trichophyton sequence over the full-length of the reverse primer, and having a final base of the reverse primer is no more than 200 bp away from a final base of SEQ ID NO: 1 in the 5′ to 3′ orientation.